Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.
Meredith N FreemanAlbert JangJason ZhuFarhad SanatiLakshminarayanan NandagopalDeepak RavindranathanArpita DesaiAudrey PhoneRoberto NussenzveigEllen JaegerSydney A CaputoVadim S KoshkinUmang SwamiArnab BasuMehmet A BilenNeeraj AgarwalOliver SartorEarle F BurgessPedro C BarataPublished in: The oncologist (2022)
In our cohort, Black men with mHSPC presented with a high proportion of de novo metastases and high-volume disease. Treatment outcomes were very favorable with ADT-based regimens. The genomic landscape suggests different molecular profile relative to White patients with potential therapeutic implications.